We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 9 start-ups with an aggregate funding of $523.7m. The average funding per company in this subset is $58.2m.
Last update to the database: Feb 18, 2025. See changelog.
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
5
Funding Rounds
$103.1m
Money raised
Inipharm is a company developing liver disease therapies.
1
Funding Rounds
$35.0m
Money raised
Develops small molecules drug candidates in infectious & metabolic diseases and oncology
2
Funding Rounds
$97.5m
Money raised
Pandorum Technologies Pvt. Ltd. is a Bangalore-based biotechnology company with a focus on tissue engineering and regenerative medicine.
4
Funding Rounds
$9.7m
Money raised
Ochre Bio is a biotechnology platform focused on rejuvenating transplant livers founded in 2019 by Jack O'Meara.
4
Funding Rounds
$49.4m
Money raised
Agonistic monoclonal antibody molecules
2
Funding Rounds
$97.6m
Money raised
Peptide therapeutic to treat complications of end-stage liver disease
1
Funding Rounds
$36.0m
Money raised
Alentis Therapeutics is a monoclonal Antibody.
2
Funding Rounds
$79.5m
Money raised
Versantis is a Switzerland-based company.
1
Funding Rounds
$16.0m
Money raised